| [1] |
ZHAO Yuqing, WANG Wei, CHEN Liyuan, YOU Huijuan, WEI Ying, WANG Qinglu, YANG Fengying.
Liver Macrophage Polarisation: a New Target for Exercise Prevention and Treatment of Non-alcoholic Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(27): 3456-3465.
|
| [2] |
WU Sha, ZHANG Daiyi, LI Jin, XUAN Qinkao, QIAN Xiaodong, ZHU Chuanwu, PU Jianhong, ZHU Li.
Correlation Analysis and Model Construction of Metabolic Associated Fatty Liver Disease and Hyperglycemia Based on a Health Examination Cohort
[J]. Chinese General Practice, 2025, 28(23): 2861-2869.
|
| [3] |
NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei.
Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks
[J]. Chinese General Practice, 2025, 28(15): 1847-1854.
|
| [4] |
NI Xuetong, AHEYEERKE Halengbieke, TANG Jianmin, CAO Tengrui, TAO Lixin, ZHENG Deqiang, LI Qiang, HAN Yumei, YANG Xinghua.
The Bidirectional Temporal Causal Association Study between Dysglycaemia and Non-alcoholic Fatty Liver Disease: Based on the Beijing Health Management Cohort
[J]. Chinese General Practice, 2025, 28(13): 1607-1613.
|
| [5] |
ZENG Jialing, MENG Yan, DENG Tingting, LI Jinhua, ZHAO Ping.
The Correlation of Non-alcoholic Fatty Liver Disease with Visceral Fat Area and Thyroid Nodules in Patients with Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(09): 1072-1083.
|
| [6] |
XU Yaolong, ZHAO Jiaxin, YANG Ligang.
Epidemic Status and Risk Factors of Non-alcoholic Fatty Liver Disease
[J]. Chinese General Practice, 2024, 27(30): 3825-3834.
|
| [7] |
FU Wei, CHENG Guobin, LYU Linya, DING Yao, WANG Yao, ZHAO Junlong.
Association of Monounsaturated Fatty Acid Intake with Nonalcoholic Fatty Liver Disease Risk in Chinese Han Adults: a Retrospective Case-control Study
[J]. Chinese General Practice, 2024, 27(29): 3623-3628.
|
| [8] |
HOU Nana, FENG Jinzhang, LIU Suohong, FENG Junfang, XUE Xiaoyan, YIN Na, CHI Gefu.
Correlation between Serum Uric Acid/Creatinine Ratio and Metabolism-associated Fatty Liver Disease
[J]. Chinese General Practice, 2024, 27(20): 2476-2482.
|
| [9] |
NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua.
Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
[J]. Chinese General Practice, 2024, 27(16): 2033-2038.
|
| [10] |
CAO Jiacen, ZHANG Hongkun, ZHAO Wen, NAN Yuemin, LI Dongdong.
Progress of Heme Oxygenase-1 Mediated Ferroptosis in Non-alcoholic Fatty Liver Disease
[J]. Chinese General Practice, 2024, 27(14): 1782-1788.
|
| [11] |
WU Xia, LIU Lan, ZHAO Yi, LI Guohui, CUI Wenlong, SUN Chenghuan, CAI Le.
Changes in the Burden of Five Common Chronic Diseases among Rural Residents in Yunnan Province in 2011 and 2021
[J]. Chinese General Practice, 2024, 27(13): 1601-1607.
|
| [12] |
ZHANG Nawen, HUANG Shaomin, TIAN Limin.
Association between Serum Osteocalcin Level and Non-alcoholic Fatty Liver Disease in Adults: a Meta-analysis
[J]. Chinese General Practice, 2024, 27(12): 1519-1524.
|
| [13] |
DOU Ziyan, QIAN Wenhong, KONG Linrun, CHEN Ye, LI Mingliang, ZHANG Jingbo.
Detection Rate of Non-alcoholic Fatty Liver Disease and Its Influencing Factors: Analysis Based on the Data of 320 000 Beijing Population
[J]. Chinese General Practice, 2024, 27(02): 144-149.
|
| [14] |
KONG Dexian, XING Yuling, SUN Wenwen, ZHANG Zhimin, ZHOU Fei, MA Huijuan.
Correlation between Estimated Glucose Disposal Rate and Metabolism-associated Fatty Liver Disease in Type 2 Diabetes
[J]. Chinese General Practice, 2023, 26(26): 3252-3258.
|
| [15] |
GAO Zhe, DUAN Kaixin, LYU Xiuqin, MA Huijuan, ZHANG Zhimei, SONG Guangyao.
Mechanism of Glucagon-like Peptide-1 Receptor Agonist Improving Liver Lipid Deposition in a Rat Model of Insulin Resistance Induced by High-fructose Diet
[J]. Chinese General Practice, 2023, 26(21): 2639-2646.
|